Ikarian Capital, LLC - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 66 filers reported holding ACUMEN PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,308,350
-58.5%
315,265
-51.9%
0.16%
-68.7%
Q2 2023$3,150,286
+204.4%
654,945
+156.9%
0.50%
+113.6%
Q1 2023$1,035,077
-24.8%
254,9450.0%0.24%
-29.2%
Q4 2022$1,376,703
-60.8%
254,945
-27.2%
0.33%
-52.6%
Q3 2022$3,511,000350,0000.70%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders